OR WAIT null SECS
January 30, 2024
The latest financial commitment adds 24,000 liters of biologics drug substance-capacity to the company’s network.
January 26, 2024
The Identification of Medicinal Product framework seeks to establish a common language for identifying, documenting, and exchanging information about medicinal products.
January 23, 2024
Acquisition is expected to strengthen company’s CDMO business, while establishing a footprint in the generics space.
January 15, 2024
Roots Analysis report suggests increase can be attributed to the growing demand for advanced therapies and biologics.
January 11, 2024
Manufacturers should leverage the knowledge base of personnel working in sterility assurance and in microbiology laboratories.
January 09, 2024
Review article explores the latest developments surrounding expression and purification strategies.
January 05, 2024
In the midst of being approved for commercial manufacturing of Pluvict, the 70,000 square-foot site was built specifically to accommodate RLT production.
January 04, 2024
Provider’s Pithampur facility is recognized for its use of Industry 4.0 technology.
December 29, 2023
Popular works in the category explore 340B guidelines, ‘smart pharma’ capabilities, and commercialization trends.
December 27, 2023
The most popular pieces pertaining to the supply chain featured ADMs, vaccine supply chains, and wholesalers.